Status:
RECRUITING
Assessment of Serum Levels of Janus Kinase 1 and 2 in Patients With Cholinergic Urticaria
Lead Sponsor:
Sohag University
Conditions:
Cholinergic Urticaria
Eligibility:
All Genders
15-55 years
Phase:
NA
Brief Summary
Cholinergic Urticaria (CholU) is as a subtype of CIndU caused by an increase in the core body temperature, such as to activate the sweating reflex. It can occur in response to physical exercise, hot b...
Eligibility Criteria
Inclusion
- The study will include 45 adult patients complaining of CholU as well as 45 healthy controls.
Exclusion
- Patients with one or more of the following criteria will be excluded:
- Pregnancy and lactation.
- Patients with systemic diseases especially those with autoimmune diseases and infections.
- Patients with skin diseases.
- Patients on medications such as: antibiotics, non-steroidal anti-inflammatory drugs, angiotensin-converting enzyme inhibitors, anticonvulsants, penicillin, combined oral contraceptives.
- Patient refusal
Key Trial Info
Start Date :
December 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 10 2024
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06201780
Start Date
December 15 2023
End Date
December 10 2024
Last Update
January 11 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Sohag university Hospital
Sohag, Egypt